|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.185 USD | -13.93% |
|
-17.11% | +13.18% |
| 06-30 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 216M 188M 174M 160M 302M 20.76B 309M 2.08B 817M 10.17B 809M 792M 34.99B | P/E 2026 * |
-2.28x | P/E 2027 * | -3.07x |
|---|---|---|---|---|---|
| Enterprise Value | 469M 409M 378M 348M 656M 45.12B 671M 4.52B 1.78B 22.1B 1.76B 1.72B 76.07B | EV / Sales 2026 * |
3.41x | EV / Sales 2027 * | 1.39x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -13.93% | ||
| 1 week | -17.11% | ||
| Current month | -14.74% | ||
| 1 month | -7.44% | ||
| 3 months | -6.82% | ||
| 6 months | +40.00% | ||
| Current year | +13.18% |
| 1 week | 8.29 |  | 10.17 |
| 1 month | 8.29 | | 10.86 |
| Current year | 5 | | 10.99 |
| 1 year | 3.65 | | 10.99 |
| 3 years | 3.51 | | 29.25 |
| 5 years | 3.51 | | 220.95 |
| 10 years | 3.51 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/05/26 | Free | Director | 15,508 | 0.0688% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% | ||
| 21/05/26 | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.93% | -17.11% | +107.21% | -65.51% | 216M | |
| -0.47% | +1.27% | +23.10% | -7.12% | 68.85B | |
| -0.33% | +1.23% | +37.62% | +190.57% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| -0.58% | +1.05% | -51.98% | -53.78% | 41.24B | |
| -1.46% | -2.88% | +65.48% | -26.10% | 30.41B | |
| -0.11% | -8.09% | +98.87% | -50.64% | 24.53B | |
| -0.64% | +2.57% | +73.89% | +83.05% | 23.42B | |
| +3.99% | +3.82% | +4.34% | +196.00% | 19.75B | |
| +0.11% | +0.22% | +71.82% | +126.13% | 16.57B | |
| Average | -1.27% | -1.32% | +47.00% | +43.22% | 32.06B | |
| Weighted average by Cap. | -0.07% | +0.07% | +32.99% | +46.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 137M 120M 111M 102M 192M 13.21B 196M 1.32B 520M 6.47B 515M 504M 22.28B | 155M 136M 125M 115M 218M 14.96B 222M 1.5B 589M 7.32B 583M 570M 25.21B |
| Net income | -121M -106M -97.59M -89.96M -170M -11.65B -173M -1.17B -459M -5.71B -454M -445M -19.65B | -135M -118M -108M -100M -188M -12.96B -193M -1.3B -510M -6.35B -505M -494M -21.84B |
| Net Debt | 253M 221M 204M 188M 354M 24.36B 362M 2.44B 959M 11.93B 950M 929M 41.08B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | $8.325 | -12.46% | 126,814 |
| 17/07/26 | $9.510 | +1.39% | 205,243 |
| 16/07/26 | $9.380 | -1.57% | 236,381 |
| 15/07/26 | $9.530 | -4.80% | 316,488 |
| 14/07/26 | $10.01 | -0.40% | 481,544 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
